{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:09:55Z","timestamp":1779318595649,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"am","delay-in-days":328,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001642","name":"Glenn Foundation for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R00AR66696"],"award-info":[{"award-number":["R00AR66696"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM128594"],"award-info":[{"award-number":["R35GM128594"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001784","name":"Pancreatic Cancer Action Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000043","name":"American Association for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA102701"],"award-info":[{"award-number":["CA102701"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U24DK10049"],"award-info":[{"award-number":["U24DK10049"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.yexcr.2021.112779","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T10:23:15Z","timestamp":1629541395000},"page":"112779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Disrupted NOS2 metabolism drives myoblast response to wasting-associated cytokines"],"prefix":"10.1016","volume":"407","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2706-9652","authenticated-orcid":false,"given":"Paige C.","family":"Arneson-Wissink","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6830-708X","authenticated-orcid":false,"given":"Jason D.","family":"Doles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2021.112779_bib1","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s00535-013-0787-0","article-title":"Cancer cachexia--pathophysiology and management","volume":"48","author":"Suzuki","year":"2013","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.yexcr.2021.112779_bib2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fphys.2014.00088","article-title":"Pancreatic cancer cachexia: a review of mechanisms and therapeutics","volume":"5","author":"Tan","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.yexcr.2021.112779_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijcard.2012.09.213","article-title":"Cachexia as major underestimated unmet medical need: facts and numbers","volume":"161","author":"Von Haehling","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.yexcr.2021.112779_bib4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.yexcr.2021.112779_bib5","first-page":"E996","article-title":"Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma","volume":"268","author":"Baracos","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.yexcr.2021.112779_bib6","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1038\/s41598-017-02088-2","article-title":"Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling","volume":"7","author":"Pettersen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2021.112779_bib7","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1172\/JCI68523","article-title":"NF-\u03baB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia","volume":"123","author":"He","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2021.112779_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13539-012-0087-1","article-title":"Cancer cachexia: impact, mechanisms and emerging treatments","volume":"4","author":"Vaughan","year":"2013","journal-title":"J. Cachexia, Sarcopenia Muscle"},{"key":"10.1016\/j.yexcr.2021.112779_bib9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.clnu.2011.10.005","article-title":"Randomized phase III clinical trial of a combined treatment with carnitine+ celecoxib\u00b1megestrol acetate for patients with cancer-related anorexia\/cachexia syndrome","volume":"31","author":"Madeddu","year":"2012","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.yexcr.2021.112779_bib10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/sj.bjc.6690077","article-title":"A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss","volume":"79","author":"McMillan","year":"1999","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.yexcr.2021.112779_bib11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1146\/annurev.cellbio.18.012502.105758","article-title":"Myogenic regulatory factors and the specification of muscle progenitors in vertebrate embryos","volume":"18","author":"Pownall","year":"2002","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.yexcr.2021.112779_bib12","article-title":"Tumor-derived cytokines impair myogenesis and alter the skeletal muscle immune microenvironment","author":"Hogan","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.yexcr.2021.112779_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metabol."},{"key":"10.1016\/j.yexcr.2021.112779_bib14","doi-asserted-by":"crossref","first-page":"622","DOI":"10.15252\/emmm.201607052","article-title":"STAT3 promotes IFN\u03b3\/TNF\u03b1-induced muscle wasting in an NF-\u03baB-dependent and IL-6-independent manner","volume":"9","author":"Ma","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.yexcr.2021.112779_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13395-020-00225-6","article-title":"A novel transplantable model of lung cancer-associated tissue loss and disrupted muscle regeneration","volume":"10","author":"Arneson-Wissink","year":"2020","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.yexcr.2021.112779_bib16","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jcsm.12561","article-title":"Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia","volume":"11","author":"Chiappalupi","year":"2020","journal-title":"J. Cachexia, Sarcopenia Muscle"},{"key":"10.1016\/j.yexcr.2021.112779_bib17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1385\/MO:22:4:353","article-title":"Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer","volume":"22","author":"Tas","year":"2005","journal-title":"Med. Oncol."},{"key":"10.1016\/j.yexcr.2021.112779_bib18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.lungcan.2007.08.005","article-title":"Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer","volume":"59","author":"Derin","year":"2008","journal-title":"Lung Canc."},{"key":"10.1016\/j.yexcr.2021.112779_bib19","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.3892\/ol.2017.6048","article-title":"IL-6 and TNF-\u03b1 promote metastasis of lung cancer by inducing epithelial-mesenchymal transition","volume":"13","author":"Shang","year":"2017","journal-title":"Oncology Lett."},{"key":"10.1016\/j.yexcr.2021.112779_bib20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"Fearon","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2021.112779_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/rco2.14","article-title":"The wasting\u2010associated metabolite succinate disrupts myogenesis and impairs skeletal muscle regeneration","volume":"3","author":"Arneson\u2010Wissink","year":"2020","journal-title":"JCSM Rapid Commun."},{"key":"10.1016\/j.yexcr.2021.112779_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fphys.2014.00032","article-title":"A metabolic link to skeletal muscle wasting and regeneration","volume":"5","author":"Koopman","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.yexcr.2021.112779_bib23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nrm1569","article-title":"Protein S-nitrosylation: purview and parameters","volume":"6","author":"Hess","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2021.112779_bib24","doi-asserted-by":"crossref","first-page":"702","DOI":"10.18632\/aging.100358","article-title":"Inducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia","volume":"3","author":"Hall","year":"2011","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.yexcr.2021.112779_bib25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fimmu.2014.00532","article-title":"Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages","volume":"5","author":"Rath","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2021.112779_bib26","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1126\/science.289.5488.2363","article-title":"NF-\u03baB-Induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia","volume":"289","author":"Guttridge","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2021.112779_bib27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.lungcan.2009.06.020","article-title":"A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and\/or poor performance non-small cell lung cancer patients (N01C9)","volume":"68","author":"Jatoi","year":"2010","journal-title":"Lung Canc."},{"key":"10.1016\/j.yexcr.2021.112779_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141572","article-title":"L-citrulline protects skeletal muscle cells from cachectic stimuli through an iNOS-dependent mechanism","volume":"10","author":"Ham","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.yexcr.2021.112779_bib29","doi-asserted-by":"crossref","first-page":"E392","DOI":"10.1152\/ajpendo.90529.2008","article-title":"Decreased Jun-D and myogenin expression in muscle wasting of human cachexia","volume":"297","author":"Ramamoorthy","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.yexcr.2021.112779_bib30","first-page":"R1020","article-title":"Cytokine-induced expression of nitric oxide synthase in C2C12 skeletal muscle myocytes","volume":"267","author":"Williams","year":"1994","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.yexcr.2021.112779_bib31","doi-asserted-by":"crossref","first-page":"6533","DOI":"10.1128\/MCB.25.15.6533-6545.2005","article-title":"NF-kappa B-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release","volume":"25","author":"Di Marco","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2021.112779_bib32","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/j.1460-2075.1996.tb00524.x","article-title":"Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants","volume":"15","author":"Buck","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.yexcr.2021.112779_bib33","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.4049\/jimmunol.1202903","article-title":"Requirement of inducible nitric oxide synthase for skeletal muscle regeneration after acute damage","volume":"190","author":"Rigamonti","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2021.112779_bib34","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013591","article-title":"Pharmacological or genetic inhibition of iNOS prevents cachexia\u2010mediated muscle wasting and its associated metabolism defects","author":"Sadek","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.yexcr.2021.112779_bib35","doi-asserted-by":"crossref","first-page":"23044","DOI":"10.1074\/jbc.M610751200","article-title":"Nitric oxide down-regulates caveolin-3 levels through the interaction with myogenin, its transcription factor","volume":"282","author":"Marti\u00ednez-Moreno","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2021.112779_bib36","doi-asserted-by":"crossref","first-page":"E1409","DOI":"10.1152\/ajpendo.90530.2008","article-title":"Attenuation of depression of muscle protein synthesis induced by lipopolysaccharide, tumor necrosis factor, and angiotensin II by \u03b2-hydroxy-\u03b2-methylbutyrate","volume":"295","author":"Eley","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"key":"10.1016\/j.yexcr.2021.112779_bib37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3177\/jnsv.59.317","article-title":"Isoflavones derived from soy beans prevent MuRF1-mediated muscle atrophy in C2C12 myotubes through SIRT1 activation","volume":"59","author":"Hirasaka","year":"2013","journal-title":"J. Nutr. Sci. Vitaminol."},{"key":"10.1016\/j.yexcr.2021.112779_bib38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.intimp.2014.02.002","article-title":"Resveratrol prevents TNF-\u03b1-induced muscle atrophy via regulation of Akt\/mTOR\/FoxO1 signaling in C2C12 myotubes","volume":"19","author":"Wang","year":"2014","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.yexcr.2021.112779_bib39","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.3892\/or.2015.3845","article-title":"Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study","volume":"33","author":"Yuan","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.yexcr.2021.112779_bib40","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1101\/gad.1820209","article-title":"Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression","volume":"23","author":"Gibbons","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.yexcr.2021.112779_bib41","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190745","article-title":"SIRT1\u2013NOX4 signaling axis regulates cancer cachexia","volume":"217","author":"Dasgupta","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2021.112779_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010538","article-title":"Quantitative metabolomics by 1 H-NMR and LC-MS\/MS confirms altered metabolic pathways in diabetes","volume":"5","author":"Lanza","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.yexcr.2021.112779_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11306-019-1544-z","article-title":"A comprehensive protocol for multiplatform metabolomics analysis in patient-derived skin fibroblasts","volume":"15","author":"Wilkins","year":"2019","journal-title":"Metabolomics"},{"key":"10.1016\/j.yexcr.2021.112779_bib44","doi-asserted-by":"crossref","first-page":"W251","DOI":"10.1093\/nar\/gkv380","article-title":"MetaboAnalyst 3.0--making metabolomics more meaningful","volume":"43","author":"Xia","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2021.112779_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-15-224","article-title":"MAP-RSeq: Mayo analysis pipeline for RNA sequencing","volume":"15","author":"Kalari","year":"2014","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.yexcr.2021.112779_bib46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.yexcr.2021.112779_bib47","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkt214","article-title":"The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote","volume":"41","author":"Liao","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2021.112779_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005401","article-title":"Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma","volume":"4","author":"Gibbons","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.yexcr.2021.112779_bib49","article-title":"Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia","author":"Yang","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.yexcr.2021.112779_bib50","doi-asserted-by":"crossref","first-page":"17441","DOI":"10.1074\/jbc.RA120.014884","article-title":"Methylarginine metabolites are associated with attenuated muscle protein synthesis in cancer-associated muscle wasting","volume":"295","author":"Kunz","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2021.112779_bib51","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/stem.783","article-title":"Nitric oxide sustains long-term skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring Vangl2 and cyclic GMP","volume":"30","author":"Buono","year":"2012","journal-title":"Stem Cell."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721003323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721003323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:18:27Z","timestamp":1762147107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482721003323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0014482721003323"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.112779","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disrupted NOS2 metabolism drives myoblast response to wasting-associated cytokines","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.112779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112779"}}